Gilead Sciences Inc. (GILD): Price and Financial Metrics
GILD Price/Volume Stats
Current price | $73.30 | 52-week high | $89.74 |
Prev. close | $74.10 | 52-week low | $63.60 |
Day low | $72.87 | Volume | 1,950,037 |
Day high | $73.87 | Avg. volume | 5,702,251 |
50-day MA | $76.67 | Dividend yield | 3.98% |
200-day MA | $80.07 | Market Cap | 91.33B |
GILD Stock Price Chart Interactive Chart >
GILD POWR Grades
- GILD scores best on the Value dimension, with a Value rank ahead of 97.15% of US stocks.
- GILD's strongest trending metric is Stability; it's been moving up over the last 177 days.
- GILD's current lowest rank is in the Momentum metric (where it is better than 3.78% of US stocks).
GILD Stock Summary
- With a market capitalization of $93,463,536,619, GILEAD SCIENCES INC has a greater market value than 97.66% of US stocks.
- GILD's went public 31.7 years ago, making it older than 83.38% of listed US stocks we're tracking.
- In terms of volatility of its share price, GILD is more volatile than merely 3.85% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to GILEAD SCIENCES INC, a group of peers worth examining would be ADI, NTES, BMY, ATVI, and RTX.
- GILD's SEC filings can be seen here. And to visit GILEAD SCIENCES INC's official web site, go to www.gilead.com.
GILD Valuation Summary
- In comparison to the median Healthcare stock, GILD's price/sales ratio is 15% lower, now standing at 3.4.
- Over the past 243 months, GILD's price/sales ratio has gone down 13.1.
Below are key valuation metrics over time for GILD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
GILD | 2023-09-22 | 3.4 | 4.4 | 17.0 | 13.6 |
GILD | 2023-09-21 | 3.4 | 4.4 | 17.1 | 13.6 |
GILD | 2023-09-20 | 3.5 | 4.5 | 17.2 | 13.7 |
GILD | 2023-09-19 | 3.4 | 4.5 | 17.2 | 13.7 |
GILD | 2023-09-18 | 3.4 | 4.5 | 17.2 | 13.7 |
GILD | 2023-09-15 | 3.4 | 4.5 | 17.2 | 13.7 |
GILD Growth Metrics
- Its 4 year net income to common stockholders growth rate is now at -60.73%.
- Its 5 year net cashflow from operations growth rate is now at -41.74%.
- The 5 year net income to common stockholders growth rate now stands at -60.73%.

The table below shows GILD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 27,281 | 9,072 | 4,592 |
2022-09-30 | 27,136 | 9,710 | 3,334 |
2022-06-30 | 27,515 | 10,100 | 4,137 |
2022-03-31 | 27,472 | 10,614 | 4,515 |
2021-12-31 | 27,305 | 11,384 | 6,225 |
2021-09-30 | 27,482 | 10,095 | 7,394 |
GILD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- GILD has a Quality Grade of B, ranking ahead of 89.87% of graded US stocks.
- GILD's asset turnover comes in at 0.406 -- ranking 114th of 682 Pharmaceutical Products stocks.
- ENTA, RDUS, and ADMS are the stocks whose asset turnover ratios are most correlated with GILD.
The table below shows GILD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.406 | 0.805 | 0.259 |
2021-06-30 | 0.402 | 0.801 | 0.179 |
2021-03-31 | 0.405 | 0.806 | 0.066 |
2020-12-31 | 0.403 | 0.815 | 0.058 |
2020-09-30 | 0.389 | 0.790 | 0.058 |
2020-06-30 | 0.375 | 0.786 | 0.009 |
GILD Price Target
For more insight on analysts targets of GILD, see our GILD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $75.84 | Average Broker Recommendation | 1.7 (Moderate Buy) |
Gilead Sciences Inc. (GILD) Company Bio
Gilead Sciences Inc. is a biopharmaceutical company that discovers, develops, and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases. Daniel O’Day has been Gilead Science’s Chief Executive Officer since March of 2019 and the company is headquartered in Foster City, California. With over 10,000 employees worldwide, the company has operations in North America, Asia, the Middle East and Europe. As of 2019, the company had global sales of $22.1 billion. Some of Gilead Science’s major competitors are Novo Nordisk A/S ADR (NVO), Biogen Inc. (BIIB), and Novartis AG ADR (NVS).
Latest GILD News From Around the Web
Below are the latest news stories about GILEAD SCIENCES INC that investors may wish to consider to help them evaluate GILD as an investment opportunity.
3 Magnificent Dividend Stocks to Buy in OctoberThere's no better time than October to invest in high-quality dividend stocks. Three Motley Fool contributors believe they've identified magnificent dividend stocks to buy in October. Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ). |
Here's Why We Think Gilead Sciences (NASDAQ:GILD) Might Deserve Your Attention TodayIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story... |
Gilead Sciences (GILD) Gains As Market Dips: What You Should KnowGilead Sciences (GILD) closed the most recent trading day at $75.53, moving +0.94% from the previous trading session. |
Unveiling Gilead Sciences (GILD)'s Value: Is It Really Priced Right? A Comprehensive GuideAn in-depth analysis of Gilead Sciences' intrinsic value, financial strength, profitability, and growth |
Why Gilead Sciences, Inc. (NASDAQ:GILD) Looks Like A Quality CompanyWhile some investors are already well versed in financial metrics (hat tip), this article is for those who would like... |
GILD Price Returns
1-mo | -3.43% |
3-mo | -4.17% |
6-mo | -10.36% |
1-year | 22.06% |
3-year | 33.81% |
5-year | 17.08% |
YTD | -12.12% |
2022 | 23.63% |
2021 | 29.95% |
2020 | -6.70% |
2019 | 7.88% |
2018 | -9.92% |
GILD Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching GILD
Want to do more research on Gilead Sciences Inc's stock and its price? Try the links below:Gilead Sciences Inc (GILD) Stock Price | Nasdaq
Gilead Sciences Inc (GILD) Stock Quote, History and News - Yahoo Finance
Gilead Sciences Inc (GILD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...